IL2 and central nervous system cancer: Therefore, to further confirm our hypothesis, we next examined the expression of several key inflammatories and immune modulators, including TNF-α, IL-2, IL-3, IL-4, and IL-12, in HK2-silenced T98 and GBM1 glioma cells.